- Details
- Recorded Date: Friday, April 3, 2020 Stephen Williams joins Alicia Morgans to speak about his new role leading a COVID-19 employee health task force at the University of Texas Medical Branch in Galveston, TX. His focus is on helping healthcare providers across the medical center — from the physicians and nurses to the custodial staff on the frontlines. He also discusses optimizing patient care, sp...
|
- Details
- Recorded Date: Friday, March 27, 2020 Elena Castro joins Alicia Morgans from Malaga, Spain to discuss the changes COVID-19 has brought to her clinical practice and lab work in Madrid. Roughly 9,000 health care professionals have been infected in Spain, as clinicians work to balance risks for their patients and the Intensive Care Units are filled with coronavirus patients. She discusses how cancer...
|
- Details
- The ORIOLE Phase 2 Randomized Clinical Trial set out to answer the question, "how effectively does stereotactic ablative radiotherapy prevent progression of disease compared with observation in men with recurrent hormone-sensitive prostate cancer with 1 to 3 metastases?" Dr Tran joins Alicia Morgans and discusses this phase 2 randomized clinical trial of 54 men, where the progression of disease at...
|
- Details
- Recorded Date: Wednesday, April 1, 2020 Reflecting on the continued COVID-19 pandemic, Chief of Urology and Director of GU Oncology at the University of Montreal Hospital Fred Saad talks with Alicia Morgans about the decisions he and his colleagues have made about how to continue clinical care for cancer patients during the outbreak. Dr. Saad notes that decisions are being made on a case by case b...
|
- Details
- Recorded Date: April 1, 2020 Joshua Meeks joins Alicia Morgans and offers his perspective on the changes, challenges, and differences in decision making impacting the management of muscle-invasive (MIBC) and non-muscle invasive bladder cancer (NMIBC) amidst the COVID-19 pandemic. Dr. Meeks emphasizes the need that has arisen for a very fast mobilization and adjustment to decision making of patient...
|
- Details
- Alicia Morgans, Associate Professor of Medicine at Northwestern University, shares her thoughts on genetically informed treatment for advanced and metastatic prostate cancer. Germline and somatic testing can have implications for patients in terms of their therapeutics and the main mutations. Morgans discusses the important germline and somatic mutations as well as the current data from clinical t...
|
- Details
- Recorded Date: April 2, 2020 The ongoing pandemic involving severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its resulting coronavirus disease 2019 (COVID-19) has caused widespread infection worldwide. Andrew DiNardo (infectious disease physician) and Paul Hegarty (urologist) join Ashish Kamat to discuss The BADAS Study: BCG vaccination As Defense Against SarsCov2: A randomized con...
|
- Details
- Recorded Date: March 19, 2020 Charles Ryan joins Alicia Morgans to provide a perspective on treating cancer patients in the current environment with the COVID-19 pandemic. They discuss impacts of COVID-19 on starting and continuing active cancer treatment regimes, staffing challenges, changes in clinic operations, and the importance of maintaining communications and counseling patients through the...
|
- Details
- Recorded Date: March 27, 2020 Jaime Landman and Monty Pal moderate this discussion featuring Dena Battle and Michael Staehler. "In the wake of the COVID-19 outbreak, governments and hospital systems are struggling to determine how to continue to provide care when resources are seriously compromised. Dena Battle, president of KCCure ran a patient survey from March 22 to March 25, asking patients to...
|
- Details
- Recorded Date: March 27, 2020 Each GU Cancer treatment community has unique challenges in the current era of the COVID-19 pandemic. Phillip Koo joins Alicia Morgans and shares the challenges he is experiencing as Chief of Diagnostic Imaging at Banner MD Anderson in Phoenix, Arizona. The demographics are an older population of cancer patients and he shares the importance of how they define which pa...
|
